🔎 Trials Near Me

Home › Glioma › Minnesota › Rochester

Glioma clinical trials in Rochester, MN

9 studies for Glioma are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

RecruitingPhase 3
  • Mayo Clinic - Rochester, Rochester
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT05303519

Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions

Recruiting
  • Mayo Clinic in Rochester, Rochester
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT04047264

A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial

Recruiting
  • Mayo Clinic in Rochester, Rochester
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT07074756

Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual Disease

RecruitingEarly phase 1
  • Mayo Clinic in Rochester, Rochester
Ages 18 and older · All sexes · Updated Jul 2, 2026 · NCT07025226

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

RecruitingPhase 1/2
  • Mayo Clinic in Rochester, Rochester
Ages 18 and older · All sexes · Updated Jun 24, 2026 · NCT07468136

Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab

RecruitingPhase 1/2
  • Mayo Clinic, Rochester
Ages 19 and older · All sexes · Updated Jun 8, 2026 · NCT06011109

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

RecruitingPhase 1/2
  • Mayo Clinic Cancer Center, Rochester
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT06810544

Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.

RecruitingPhase 1
  • Mayo Clinic in Rochester, Rochester
Ages 18 to 75 · All sexes · Updated Mar 24, 2026 · NCT06482905

Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma

RecruitingEarly phase 1
  • Mayo Clinic in Rochester, Rochester
Ages 18 and older · All sexes · Updated Nov 4, 2025 · NCT05717153

Glioma trials in other cities

Other studies in Rochester

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.